Internal Medicine, Hematology & Oncology · Santa Clara, CA
NPI
1114180197
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
710 Lawrence Expy, Dept. 440
Santa Clara, CA, 95051
Phone (408) 851-4328
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
985 services
Medicare patients, 2024
11
Average age 67
Drug cost, 2024
$5.4M
1,510 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Samina Ahmed prescribed most often to Medicare patients was Letrozole, with 406 prescriptions and refills. In total Samina Ahmed wrote 1,510 Medicare prescriptions that cost $5.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Letrozole Generic | 406 | 1,137 | 131 | $7,850 |
| Anastrozole Generic | 111 | 320 | 39 | $3,010 |
| Ibrance Palbociclib | 62 | 62 | Under 11 | $961K |
| Lenalidomide Generic | 58 | 58 | Under 11 | $666K |
| Ondansetron Hcl Generic | 53 | 53 | 22 | $455 |
| Dexamethasone Generic | 52 | 65 | 18 | $950 |
| Tagrisso Osimertinib Mesylate | 46 | 46 | Under 11 | $663K |
| Gabapentin Generic | 46 | 98 | 14 | $567 |
| Kisqali Ribociclib Succinate | 45 | 45 | Under 11 | $706K |
| Hydroxyurea Generic | 44 | 133 | 13 | $1,728 |
| Exemestane Generic | 43 | 115 | 11 | $3,149 |
| Entecavir Generic | 40 | 67 | Under 11 | $1,053 |
| Brukinsa Zanubrutinib | 39 | 39 | Under 11 | $513K |
| Calquence Acalabrutinib Maleate | 29 | 29 | Under 11 | $330K |
| Potassium Chloride Generic | 26 | 31 | Under 11 | $469 |
Brand drugs: 367 claims; generic drugs: 1,143 claims; opioid claims: 13.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Samina Ahmed were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.